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We examined consumption of animal foods, protein and calcium in relation to risk of prostate cancer among 142 251 men in the
European Prospective Investigation into Cancer and Nutrition. Associations were examined using Cox regression, stratified by
recruitment centre and adjusted for height, weight, education, marital status and energy intake. After an average of 8.7 years of
follow-up, there were 2727 incident cases of prostate cancer, of which 1131 were known to be localised and 541 advanced-stage
disease. A high intake of dairy protein was associated with an increased risk, with a hazard ratio for the top versus the bottom fifth of
intake of 1.22 (95% confidence interval (CI): 1.07–1.41, Ptrend¼ 0.02). After calibration to allow for measurement error, we
estimated that a 35-g day1 increase in consumption of dairy protein was associated with an increase in the risk of prostate cancer of
32% (95% CI: 1–72%, Ptrend¼ 0.04). Calcium from dairy products was also positively associated with risk, but not calcium from other
foods. The results support the hypothesis that a high intake of protein or calcium from dairy products may increase the risk for
prostate cancer.
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Little is known about the aetiology of prostate cancer. It has been
suggested that a high intake of animal protein might increase the
incidence of prostate cancer by enhancing growth hormone
activity (Sato, 1963). Ecological studies have shown that milk
intake is strongly correlated with both incidence and mortality
from prostate cancer (Ganmaa et al, 2002; Colli and Colli, 2006). It
has been hypothesised that a high intake of dairy protein may
increase prostate cancer risk by increasing the production of
insulin-like growth-factor-I (IGF-I), which in turn may promote
development of prostate cancer (Renehan et al, 2004; Allen et al,
2007). An alternative hypothesis is that a high intake of calcium,
primarily from dairy products, may increase risk by suppressing
the synthesis of 1,25-dihydroxyvitamin D (Giovannucci, 1998).
In the present study, we investigated prostate cancer risk in
relation to consumption of animal foods, protein and calcium
among 142 520 men in the European Prospective Investigation into
Cancer and Nutrition (EPIC).
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MATERIALS AND METHODS
The European Prospective Investigation into Cancer and
Nutrition is a multicentre prospective study designed to
investigate the relationships between diet, lifestyle, environmental
factors and cancer. The methods of recruitment and study
design are fully described elsewhere (Riboli et al, 2002). The total
cohort comprises approximately 500 000 men and women
recruited in 28 centres in 10 European countries: Denmark,
France, Germany, Greece, Italy, the Netherlands, Norway,
Spain, Sweden and the United Kingdom (UK). In this paper, we
describe data for men from 19 centres in eight of these
countries, no data being available for France or Norway because
only women were recruited in these two countries. Men were
recruited between 1989 and 2004, and the median age at
recruitment was 52 years.
The men included in this analysis were recruited from the
population of defined geographical areas in each of the eight
countries (general population in most centres, blood donors in
Ragusa and Turin in Italy and in the Spanish centres), except for
most of those in the Oxford subcohort, who were recruited
throughout the United Kingdom to enroll a large number of
vegetarians. Study participants were almost all white Europeans.
Eligible men were invited to participate in the study, and those
who accepted gave informed consent and completed question-
naires on their diet, lifestyle and medical history. Approval for this
study was obtained from the ethical review boards of the
International Agency for Research on Cancer (IARC) and from
local ethics committees in each country.
Men were not eligible for this analysis if they had previously
been registered as having cancer at the time of completing the
baseline questionnaire, if they had no dietary or nondietary data,
or if they had missing dates of cancer diagnosis or follow-up.
Individuals were also excluded if they were in the top or bottom
1% of the distribution of the ratio of reported energy intake to
energy requirement, to reduce the impact of implausible extreme
values in the analysis (Ferrari et al, 2002). Following these
exclusions, complete data on diet and follow-up for cancer were
available for 142 520 men out of the 148 372 men in the original
data set.
Dietary intake during the year before enrolment was measured
by country-specific validated food frequency questionnaires
(FFQs) or diet histories, as previously described (Riboli et al,
2002). For this analysis, animal foods included total meat and meat
products (and the subcategories red meat, poultry and processed
meat), fish and shellfish (and the subcategories white fish and fatty
fish), dairy products (and the subcategories milk and milk
beverages, yoghurt and cheese) and eggs. Estimated daily nutrient
intakes were calculated by multiplying the nutrient content of each
food of a specific portion size by the frequency of consumption as
stated on the FFQ using national food tables from each country.
Greece and Umea˚ were not included in the analyses of animal,
dairy or plant protein, or Greece in that of calcium intake, because
the relevant data were not available.
The nondietary questions covered education and socioeconomic
status, occupation, history of previous illness and disorders
or surgical operations, lifetime history of consumption of
tobacco and alcoholic beverages, and physical activity. Height
and weight were measured at recruitment, except for most of the
men in the Oxford cohort among whom height and weight were
self-reported.
Follow-up is provided by population-based cancer registries in
six of the participating countries: Denmark, Italy, the Netherlands,
Spain, Sweden and the United Kingdom. In Germany and Greece,
follow-up is via self-completed questionnaires, and self-reported
incident cancers are verified through medical records. Data on
vital status in most EPIC centres were collected from mortality
registries at the regional or national level, in combination with data
collected by active follow-up (Greece). By March 2007, complete
follow-up data had been reported to IARC up to December 2003 or
December 2004 for most centres. Follow-up was censored at the
date of diagnosis of prostate cancer, or at the date of diagnosis of
other cancers, death, emigration or end of follow-up, whichever
came first. The 10th Revision of the International Statistical
Classification of Diseases, Injuries and Causes of Death (ICD) was
used, and cancer of the prostate as analysed here was defined as
code C61.
Data on TNM stage and Gleason grade were collected from each
centre, where possible. In all, 1672 cases (61%) had information on
stage and 1630 cases (60%) had information on grade. Tumours
were classified as localised (TNM staging score of T0/T1/T2 and
N0/NX and M0, or stage coded in the recruitment centre as
localised; n¼ 1131) or advanced (T3 or T4 or N1þ or M1, or stage
coded in the recruitment centre as metastatic; n¼ 541) or
unknown. Subset analyses were also conducted for low-grade
(Gleason sum o7 or equivalent (cases coded as well differentiated
or moderately differentiated); n¼ 982) and high-grade disease
(Gleason sum X7 or equivalent (cases coded as poorly differ-
entiated or undifferentiated); n¼ 648), or unknown.
Statistical analyses
Analyses of the associations of foods and nutrients and potential
confounding factors with risk were conducted using Cox regres-
sion. Data were stratified by centre, and age was used as the
underlying time scale in all models.
Food and nutrient intakes estimated from the dietary ques-
tionnaires (Riboli et al, 2002) were calculated in g day1, unless
otherwise stated. Dietary intakes were primarily analysed as
categorical variables, based on quintiles of the distribution among
noncases across all EPIC centres combined. Tests for linear trend
were conducted using continuous values for each food and
nutrient variable; nutrient increments were set at 35 g day1 for
all protein variables and 0.3 g day1 for all calcium variables
(corresponding to approximately 1 s.d. in total protein and calcium
intake, respectively) to make comparable assessments of intake
with risk. All models were adjusted for educational level (no
degree, degree or higher, unknown), marital status (married/
cohabiting, not married/cohabiting and unknown), height (o170,
170–174, 175–179 and X180 cm), weight (o70, 70–79, 80– 89
and X90 kg) and energy intake (MJ day1; continuous). Further
adjustment for combined occupational and recreational physical
activity (physically inactive, moderately inactive, moderately
active, active and not known) smoking (never, past, current and
unknown) and alcohol (continuous) made no appreciable differ-
ence to the results so these covariates were not included in the final
models.
To improve the comparability of dietary data across participa-
ting centres and to correct for measurement error in relative risk
estimates, dietary intakes from the questionnaires were calibrated
using a fixed-effects linear model in which centre and gender-
specific 24-h recall data from an 8% random sample of the cohort
(Slimani et al, 2002) were regressed on the FFQ intakes (Ferrari
et al, 2007).
Separate analyses were conducted for localised and advanced
disease, and also for low-grade and high-grade disease. Hetero-
geneity between these subgroups was tested by fitting stratified
Cox models based on competing risks, comparing the risk
coefficients and standard errors in the subgroups of interest after
excluding cases of uncertain stage and grade as previously
described (Smith-Warner et al, 2006). To evaluate whether
preclinical disease may have influenced results, additional analyses
were conducted after excluding the first 4 years of follow-up. We
also examined whether the association between animal foods and
risk was modified by age at recruitment (o60 and X60 years).
Heterogeneity in the association with prostate cancer risk between
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countries was assessed using w2 tests. All P-values presented are
two-tailed and P-values below 0.05 were considered statistically
significant. Analyses were performed using Stata v. 9 (Stata
Corporation, Texas, USA).
RESULTS
Details of participants from the eight countries are shown in
Table 1. After an average of 8.7 years of follow-up, 2727 men were
diagnosed with prostate cancer among the 142 520 participants
included in this study, with a total of 1 236 265 person-years. The
median age at diagnosis of prostate cancer was 66 years (range:
44–95 years). There was an approximate two-fold variation in the
calibrated median intake of total meat and meat products among
participating countries, and a three- to six-fold variation in the
intake of red meat, poultry, milk and milk beverages, cheese and
eggs; the median intake of processed meat and yoghurt varied by
more than 10-fold among countries. On the basis of 24-h recall
data, protein intake was largely derived from meat (32%), cereals
(18%), cheese (9%) and milk (7%). Overall, 17% of protein was
derived from dairy products, although this varied from 11% in
Spain to 23% in Sweden. Dietary calcium was largely derived from
dairy products (53%), with milk, cheese and yoghurt contributing
22, 23 and 8%, respectively. Variation in the proportion of calcium
derived from dairy foods ranged from 43% in Germany to 65% in
Sweden. There was a very strong correlation between dairy protein
and dairy calcium intake (r¼ 0.98).
Differences in nondietary characteristics at baseline between
prostate cancer cases and noncases are shown in Table 2. Cases
were older, less likely to be current smokers or physically active,
and were more likely to be married than noncases. In Cox
regression analyses, being educated to a degree level or higher, and
being married or cohabiting, were each associated with a
statistically significant increased risk (results not shown) and
were therefore included in subsequent models of dietary intake
and risk.
Table 3 shows hazard ratios (HRs) for prostate cancer in relation
to consumption of meat, fish, dairy foods and eggs, stratified by
centre and adjusted for education, marital status, height, weight
and energy intake. Overall, there was no association between any
of the meat or fish products or eggs and risk. For dairy products,
yoghurt intake was associated with an increased risk (the HR for
the highest versus the lowest fifth of intake was 1.17, 95%
confidence interval (CI): 1.04–1.31; Ptrend¼ 0.02), but there was no
evidence of an association with intakes of milk and milk beverages
or cheese.
Total protein intake was nonsignificantly positively associated
with increased risk (HR in the highest versus the lowest fifth of
intake¼ 1.17, 95% CI: 0.96–1.44; Ptrend¼ 0.07) (Figure 1). Protein
from dairy foods was significantly associated with an increased
risk (HR for the highest versus lowest fifth was 1.22, 95% CI:
1.07– 1.41; Ptrend¼ 0.02). Protein derived from all animal or all
plant foods was not significantly associated with risk. Total dietary
calcium intake and calcium intake from dairy foods were also
associated with an increased risk (HR for the highest versus the
lowest fifth of intake were 1.17, 95% CI: 1.00–1.35; Ptrend¼ 0.01
for total dietary calcium, and 1.18, 95% CI: 1.03–1.36; Ptrend¼ 0.02
for dairy calcium). Calcium intake from nondairy foods was not
associated with risk.
Table 4 shows the HRs for prostate cancer associated with
consumption of protein and calcium evaluated as continuous
variables, before and after calibration. Protein intake from dairy
products, total dietary calcium and calcium from dairy products
were all associated with a significant increase in risk, which was
larger after calibration. An increment of 35 g day1 dairy protein
Table 1 Description of the study cohorts with men participating in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Country
Number of
men
Cases
(nos.)
Localised
(nos.)
Advanced
(nos.) Person-years
Median age at recruitment
(5th–95th percentile)
Denmark 26 267 368 188 104 198 584 56 (50–64)
Germany 21 567 420 240 92 176 902 52 (41–63)
Greece 10 593 40 17 8 73 980 52 (33–72)
Italy 14 009 145 27 30 120 984 49 (38–62)
The Netherlands 9782 59 11 29 82 852 43 (23–58)
Spain 15 150 206 144 23 156 070 49 (40–63)
Sweden 22 299 1013 323 157 233 424 51 (30–68)
UK 22 853 476 181 98 193 469 52 (28–73)
All countries 142 520 2727 1131 541 1 236 265 52 (33–67)
Table 2 Baseline nondietary characteristics of prostate cancer cases and
noncases in EPIC
Characteristic Cases Noncases
Number of subjects 2727 139 793
Age at recruitment (years)a 60.3 (6.7) 51.5 (10.1)
Height (cm)a 174.3 (7.0) 174.7 (7.3)
Weight (kg)a 80.2 (11.4) 80.9 (12.0)
BMI (kg m2)a 26.4 (3.4) 26.5 (3.6)
Smoking, %
Never 33.6 32.9
Former 43.8 36.1
Current 21.5 29.6
Unknown 1.1 1.4
Combined total physical activity, %a
Inactive 14.6 18.5
Moderately inactive 30.5 26.2
Moderately active 36.5 32.5
Active 6.9 12.3
Unknown 11.5 10.5
Education, %
Below degree level 71.1 70.8
Degree level 25.0 26.2
Unknown 3.9 3.0
Marital status, %
Married 65.8 55.8
Not married 12.0 13.2
Unknown 22.2 31.0
aValues are means (and s.d. in parentheses).
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was associated with an HR of 1.32 (95% CI: 1.01–1.72;
Ptrend¼ 0.04) and increments of 0.3 g day1 of total calcium and
dairy calcium were associated with HRs of 1.09 (95% CI: 1.01–1.16;
Ptrend¼ 0.02) and 1.07 (95% CI: 1.00–1.14; Ptrend¼ 0.04),
respectively.
The associations between calibrated estimates of protein
and calcium intake and risk according to stage and grade of
disease are shown in Table 5. Risk estimates for most nutrients
were slightly higher for localised disease (n¼ 1131) than advanced
disease (n¼ 541), but none reached statistical significance.
No nutrients were associated with low-grade disease, but
intakes of dairy protein, total dietary calcium and dairy calcium
were significantly associated with an increased risk of high-grade
disease (HRs of 1.76, 95% CI: 1.06– 2.95; Ptrend¼ 0.03 for an
increment increase of 35 g day1 dairy protein; and 1.19, 95% CI:
1.04– 1.37; Ptrend¼ 0.01 and 1.16, 95% CI: 1.03– 1.32; Ptrend¼ 0.02
for an increment increase of 0.3 g day1 of total calcium and
dairy calcium, respectively). However, the tests for hetero-
geneity between the risk estimates for low-grade and
high-grade disease were not statistically significant for any of
these nutrients.
The associations between nutrients and prostate cancer risk
were similar below the age of 60 years at recruitment (n¼ 1222)
and at older ages (n¼ 1505), although some significant associa-
tions were found for calibrated intakes among men below the age
of 60 years at recruitment (HR¼ 1.43, 95% CI: 1.02–2.03, for
35 g day1 of dairy protein, HR¼ 1.10, 95% CI: 1.01– 1.20, for
0.3 g day1 for both total and dairy calcium). To examine whether
cancers diagnosed soon after recruitment may have influenced the
results, the analyses were repeated after excluding the first 4 years
of follow-up, leaving 2010 cases and 134 944 noncases, but they did
not materially change (results not shown). There was no evidence
of heterogeneity between countries in the association of protein or
calcium intake with risk of overall prostate cancer (results not
shown).
DISCUSSION
In this prospective study of 2727 cases of prostate cancer, the
consumption of protein and calcium derived from dairy foods
were significantly positively associated with risk. Strengths of the
EPIC study are its prospective design, the large number of prostate
cancer cases and the wide range of animal food intakes. We were
also able to consider other possible risk factors such as education,
marital status, alcohol intake, height, weight, energy intake,
smoking and physical activity. Data on PSA use in the EPIC
cohort are not available, but the annual rates of PSA testing in
middle aged men within some of the participating countries
suggest relatively low rates, of 6% in England and Wales, 7% in the
Netherlands, 9% in Spain and 16% in Italy, compared with
approximately 38% in white Americans (Etzioni et al, 2002;
Paez et al, 2002; Otto et al, 2003; D’Ambrosio et al, 2004;
Melia et al, 2004).
Our results are compatible with the hypothesis that a high intake
of dairy protein is associated with increased prostate cancer risk
(Gao et al, 2005). Although we found no association with milk intake
per se, protein and calcium intake derived from dairy foods, and also
yoghurt intake, were significantly associated with increased risk. This
apparent discrepancy may, in part, be because dairy protein and
calcium are derived from a combination of dairy products, which on
their own only exhibit a weak association with risk.
It has been hypothesised that the high protein content of dairy
products may increase risk by increasing circulating levels of IGF-
I, as shown in several cross-sectional studies (Holmes et al, 2002;
Giovannucci et al, 2003; Heald et al, 2003; Larsson et al, 2005;
Norat et al, 2007) and some intervention trials (Heaney et al, 1999;
Hoppe et al, 2004). Vegan men and women (who consume no dairy
or other animal products) have significantly lower serum IGF-I
levels than both lacto-ovo vegetarians and meat eaters (Allen et al,
2000, 2002), which may be due to their lower intake of essential
amino acids (Allen et al, 2002). Intervention studies have
Table 3 Multivariate hazard ratios (HRs) and 95% confidence intervals (CIs) for prostate cancer among 142 520 men in the EPIC cohort by fifths of
observed intake of meat, fish and dairy foods
Fifth of food intake
1 2 3 4 5
Food
No. of
cases
HR
(95% CI)
No. of
cases
HR
(95% CI)
No. of
cases
HR
(95% CI)
No. of
cases
HR
(95% CI)
No. of
cases
HR
(95% CI) Ptrend
a
Meat and meat
productsb
442 1.00 (referent) 601 1.08 (0.95–1.23) 512 0.96 (0.84–1.10) 473 0.99 (0.86–1.15) 413 0.97 (0.83–1.14) 0.85
Red meatb 499 1.00 (referent) 602 1.03 (0.91–1.17) 532 1.00 (0.88–1.13) 437 0.97 (0.84–1.12) 371 0.96 (0.82–1.12) 0.69
Poultry 738 1.00 (referent) 534 1.05 (0.93–1.18) 517 1.11 (0.98–1.25) 471 1.07 (0.95–1.21) 467 1.12 (0.98–1.27) 0.06
Processed meat 345 1.00 (referent) 586 1.06 (0.92–1.22) 577 1.03 (0.89–1.19) 629 1.03 (0.89–1.20) 590 0.93 (0.79–1.09) 0.54
Fish and fish products 431 1.00 (referent) 464 1.00 (0.87–1.14) 582 1.09 (0.96–1.25) 585 1.02 (0.90–1.17) 665 1.05 (0.91–1.20) 0.56
White fishc 436 1.00 (referent) 260 1.08 (0.91–1.27) 319 0.97 (0.83–1.13) 452 0.99 (0.86–1.14) 554 1.03 (0.90–1.18) 0.90
Fatty fish 579 1.00 (referent) 382 1.04 (0.91–1.19) 562 1.05 (0.94–1.19) 538 1.03 (0.92–1.17) 666 1.07 (0.95–1.21) 0.95
Milk and milk
beverages
470 1.00 (referent) 489 1.00 (0.88–1.14) 517 0.98 (0.86–1.11) 594 0.97 (0.85–1.10) 657 1.01 (0.89–1.16) 0.23
Yoghurt 684 1.00 (referent) 351 0.91 (0.79–1.06) 434 1.08 (0.94–1.23) 516 1.09 (0.96–1.23) 742 1.17 (1.04–1.31) 0.02
Cheese 552 1.00 (referent) 584 0.98 (0.87–1.11) 575 1.00 (0.89–1.14) 591 1.10 (0.97–1.24) 425 1.04 (0.90–1.20) 0.58
Eggsb 518 1.00 (referent) 474 0.98 (0.87–1.11) 441 0.98 (0.86–1.12) 514 0.99 (0.87–1.12) 494 0.96 (0.84–1.10) 0.33
All models are stratified by centre and adjusted for education, marital status, height, weight and energy intake. Median intakes in each fifth based on 24-h recall data are: 76, 119,
140, 162 and 194 g day1 for total meat and meat products; 28, 50, 61, 72 and 90 g day1 for red meat; 9, 13, 19, 22 and 32 g day1 for poultry; 16, 42, 53, 71 and 88 g day1 for
processed meat; 18, 29, 38, 49 and 78 g day1 for fish and fish products; 13, 13, 17, 25 and 43 g day1 for white fish; 9, 13, 16, 20 and 32 g day1 for fatty fish; 34, 90, 200, 265 and
466 g day1 for milk and milk beverages; 12, 10, 26, 59 and 135 g day1 for yoghurt (also includes fromage blanc and petits suisses); 15, 28, 35, 40 and 57 g day1 for cheese; and 9,
12, 15, 20 and 32 g day1 for eggs. aP-values for trend are obtained by entering the continuous food intake variable in the model. bUmea˚ excluded due to missing data. cGermany
and Umea˚ excluded due to missing data.
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also shown that protein restriction can lower IGF-I levels in both
animals (Miura et al, 1992; Takenaka et al, 2000; Katsumata et al,
2002) and humans (Smith et al, 1995), and that the increases in
IGF-I levels following re-feeding are strongly related to the
essential amino-acid component of the diet (Clemmons et al,
1985). The effects of protein and especially dairy protein on
IGF-I could be important, because high serum IGF-I levels have
been associated with a moderately increased risk of prostate
cancer in several large-scale prospective studies including EPIC
(Renehan et al, 2004; Allen et al, 2007). However, few studies
have reported on protein intake in relation to risk (Severson et al,
1989; Schuurman et al, 1999; Chan et al, 2000), and,
to our knowledge, this is the first study to examine specifically
the association of dairy protein in risk.
Nutrient (fifth) Cases HR (95% CI) HR and 95% CI P for trenda
628
582
530
509
478
469
508
474
523
427
428
510
575
578
596
589
572
495
451
294
515
491
541
555
585
448
505
567
586
581
588
508
539
562
490
Protein
Animal proteinbc
Plant proteinbc
Dairy proteinb
Dairy calciumb
Non-dairy calciumb
Calciumb
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.05 (0.92–1.20)
1.09 (0.96–1.22)
1.02 (0.90–1.16)
1.08 (0.95–1.23)
1.08 (0.95–1.23)
1.18 (1.03–1.36)
0.93 (0.82–1.06)
0.99 (0.87–1.13)
0.94 (0.82–1.07)
1.00 (0.86–1.15)
1.07 (0.91–1.24)
1.02 (0.85–1.23)
0.6 0.8 1.0 1.3 1.6
0.58
0.02
0.01
0.60
0.02
0.14
0.07
1.00 (0.87–1.15)
1.17 (1.00–1.35)
1.04 (0.91–1.19)
1.08 (0.93–1.26)
1.01 (0.82–1.23)
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0.97 (0.81–1.15)
0.90 (0.78–1.04)
1.00 (0.85–1.18)
1.17 (0.96–1.44)
Figure 1 Multivariate HRs and 95% CIs for prostate cancer by quintile of observed intake of protein and calcium. All models are stratified by centre and
adjusted for education, marital status, height, weight and energy intake. Mean intakes in each quintile based on 24-h recall data are: 80, 90, 98, 105 and
121 g day1 for protein; 47, 59, 64, 69 and 80 g day1 for animal protein; 10, 14, 17, 21 and 27 g day1 for dairy protein; 29, 33, 36, 38 and 47 g day1 for
plant protein; 0.78, 0.92, 1.01, 1.10 and 1.32 g day1 for total calcium; 0.30, 0.44, 0.56, 0.68 and 0.88 g day1 for dairy calcium; and 0.38, 0.42, 0.45, 1.8 and
5.5 g day1 for nondairy calcium. aP-values for trend are obtained by entering the continuous variable in the model. bGreece excluded. cUmea˚ excluded.
Table 4 Multivariate hazard ratios (HRs) and 95% confidence intervals (CIs) for prostate cancer among 142 520 men in the EPIC cohort for specified
increments in observed (uncalibrated) and calibrated intakes of protein and calcium
Increment
Observed Calibrated
Foods and nutrients (g day1) HR (95% CI) Ptrend HR (95% CI) Ptrend
Protein 35 1.09 (0.99–1.19) 0.07 1.24 (0.97–1.59) 0.08
Animal proteina 35 1.07 (0.98–1.17) 0.14 1.07 (0.89–1.29) 0.47
Dairy proteinb 35 1.16 (1.03–1.31) 0.02 1.32 (1.01–1.72) 0.04
Plant proteina 35 0.95 (0.77–1.17) 0.60 0.94 (0.59–1.49) 0.80
Calciumb 0.3 1.04 (1.01–1.08) 0.01 1.09 (1.01–1.16) 0.02
Dairy calciumb 0.3 1.04 (1.01–1.08) 0.02 1.07 (1.00–1.14) 0.04
Nondairy calciumb 0.3 1.04 (0.90–1.19) 0.58 1.18 (0.83–1.68) 0.36
All models are stratified by centre and adjusted for education, marital status, height, weight and energy intake. aGreece and Umea˚ excluded due to missing data. bGreece
excluded due to missing data.
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An alternative hypothesis is that dairy products may increase
prostate cancer risk via their high calcium content, and our finding
of a positive association with calcium intake is consistent with
some (Chan et al, 2001; Gao et al, 2005; Tseng et al, 2005;
Giovannucci et al, 2006; Kesse et al, 2006; Ahn et al, 2007; Mitrou
et al, 2007), but not all, prospective studies (Koh et al, 2006; Severi
et al, 2006; Rohrmann et al, 2007). It has been suggested that a
high calcium intake may increase risk by suppressing the synthesis
of 1,25-dihydroxyvitamin D, which has an antitumour effect on
human prostatic cells in vitro (Giovannucci, 1998). However, a
randomised controlled trial showed that, although long-term
calcium supplementation (1.2 g calcium per day) slightly reduced
serum 1,25-dihydroxyvitamin D concentrations, it was not
associated with increased risk, although this trial was too small
to exclude a moderate effect (upper CI in treated group 1.32; Baron
et al, 2005). In addition, the evidence that circulating levels of
either 1,25-dihydroxyvitamin D or its precursor 25-dihydroxyvi-
tamin D are inversely related to risk is inconsistent (Giovannucci,
2005). Overall, the evidence that a high calcium intake affects risk
through mechanisms related to vitamin D production appears
limited. It is possible that the association seen with dairy calcium
intake may be due to its high correlation with other aspects of
dairy foods, particularly protein, although it is difficult to separate
out their independent effects. Further, although the intake of
nondairy calcium was low, the finding that it was not associated
with risk suggests that another component of dairy foods may be
of greater aetiological relevance.
Some studies have suggested that the associations with dairy
foods and calcium intake are stronger for aggressive disease (Gao
et al, 2005; Giovannucci et al, 2006). In the current study, although
these associations were slightly stronger for high-grade disease and
for men recruited before the age of 60 years, the differences
between the groups were not significant, and there were no
comparable differences between localised and advanced-stage
disease. Several previous studies have found that risk is
particularly elevated in men with a total calcium intake (i.e., diet
plus supplement intake) above 2 g day1 (Rodriguez et al, 2003;
Giovannucci et al, 2006; Ahn et al, 2007; Mitrou et al, 2007).
However, we had no information on supplement use and although
the present study found a significantly elevated risk in the top fifth
of dietary intake, the mean intake of this category, based on 24-h
recall data, was 1.3 g day1; less than 1% of the cohort had a dietary
calcium intake of 2 g day1 or more. As such, we had limited power
to assess whether very high calcium intake is associated with
increased risk.
Our finding that total meat or red meat intake is not associated
with prostate cancer risk is consistent with most previous
prospective studies (Snowdon, 1988; Mills et al, 1989; Hsing
et al, 1990; Chan et al, 2000; Allen et al, 2004; Cross et al, 2005;
Rohrmann et al, 2007), although some found positive associations
with red meat (Michaud et al, 2001), hamburgers (Veierod et al,
1997), beef (Le Marchand et al, 1994) or cooked processed meat
(Rodriguez et al, 2006) for either total or advanced prostate cancer.
For fish, our results, which are based on a wide range of intake,
provide no evidence that intake is associated with risk, and is
consistent with most previous studies (Severson et al, 1989; Hsing
et al, 1990; Le Marchand et al, 1994; Gronberg et al, 1996;
Schuurman et al, 1999), although some have reported a negative
(Terry et al, 2001; Augustsson et al, 2003) or positive association
(Mills et al, 1989; Allen et al, 2004).
Our study has some limitations. As in other large epidemiolo-
gical studies, dietary intake is estimated using relatively simple
dietary questionnaires that are subject to measurement errors
leading to attenuated risk estimates. Nonetheless, the question-
naires in all EPIC centres were validated, and dietary intakes were
calibrated with measures from a standardised 24-h diet recall
method.
In conclusion, the results from this large prospective study are
consistent with the hypothesis that a high intake of protein or
calcium from dairy products may increase prostate cancer risk.
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Table 5 Multivariate hazard ratios (HRs) and 95% confidence intervals (CIs) by stage and grade of prostate cancer for specified increments in calibrated
intakes of protein and calcium in EPIC
Localised stage disease
(n¼1403)
Advanced-stage disease
(n¼ 541)
Low-grade disease
(n¼ 982)
High-grade disease
(n¼ 648)
Nutrient
Increment
(g day1) HR (95% CI) Ptrend HR (95% CI) Ptrend Pdifference HR (95% CI) Ptrend HR (95% CI) Ptrend Pdifference
Protein 35 1.37 (0.95–1.99) 0.10 1.12 (0.64–1.94) 0.70 0.54 1.13 (0.76–1.70) 0.54 1.08 (0.65–1.79) 0.78 0.87
Animal proteina 35 1.23 (0.91–1.66) 0.17 0.95 (0.62–1.45) 0.82 0.33 0.92 (0.66–1.28) 0.63 1.03 (0.71–1.49) 0.90 0.67
Dairy proteinb 35 1.22 (0.81–1.85) 0.34 1.28 (0.73–2.22) 0.39 0.90 1.10 (0.68–1.78) 0.69 1.76 (1.06–2.95) 0.03 0.19
Plant proteina 35 0.88 (0.42–1.84) 0.73 0.75 (0.27–2.10) 0.58 0.81 1.14 (0.53–2.43) 0.74 0.63 (0.24–1.67) 0.35 0.34
Calciumb 0.3 1.07 (0.96–1.19) 0.25 1.05 (0.91–1.22) 0.49 0.90 1.00 (0.88–1.14) 0.96 1.19 (1.04–1.37) 0.01 0.07
Dairy calciumb 0.3 1.06 (0.96–1.17) 0.28 1.04 (0.91–1.19) 0.57 0.86 1.01 (0.90–1.14) 0.82 1.16 (1.03–1.32) 0.02 0.12
Nondairy calciumb 0.3 1.14 (0.66–1.99) 0.63 1.04 (0.47–2.29) 0.93 0.85 0.83 (0.44–1.56) 0.57 1.21 (0.57–2.56) 0.62 0.46
All models are stratified by centre and adjusted for education, marital status, height, weight and energy intake. aGreece and Umea˚ excluded due to missing data. bGreece
excluded due to missing data.
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